Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.69 |
| ▸ | PKM | P14618 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | GMNN | O75496 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.64 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.64 |
| ▸ | THPO | P40225 | 1/20 | 0.64 |
| ▸ | MTOR | P42345 | 1/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | HBB | P68871 | 1/20 | 0.64 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.60 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.60 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.60 |
| ▸ | PGK1 | P00558 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1494485 | 1.00 | KDM4E (0.69) | KDM4EPKMLMNAGMNNALDH1A1 | |
| SCHEMBL1494490 | 1.00 | KDM4E (0.69) | KDM4EPKMLMNAGMNNALDH1A1 | |
| SCHEMBL23710624 | 1.00 | KDM4E (0.69) | KDM4EPKMLMNAGMNNALDH1A1 | |
| SCHEMBL8970975 | 0.89 | ADORA3 (0.60) | KDM4EPKMLMNAGMNNALDH1A1 | |
| SCHEMBL8970966 | 0.89 | ADORA3 (0.60) | KDM4EPKMLMNAGMNNALDH1A1 | |
| SCHEMBL9150473 | 0.89 | KDM4E (0.56) | KDM4EPKMLMNAGMNNALDH1A1 | |
| SCHEMBL25342616 | 0.86 | KDM4E (0.56) | KDM4EPKMLMNAGMNNALDH1A1 | |
| SCHEMBL6687832 | 0.86 | KDM4E (0.71) | KDM4EPKMLMNAGMNNALDH1A1 | |
| SCHEMBL6300238 | 0.85 | KDM4E (0.69) | KDM4EPKMLMNATP53ADORA3 | |
| SCHEMBL3660398 | 0.85 | KDM4E (0.69) | KDM4EPKMLMNAGMNNALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713450-A1 | ENGINEERED CONSTRUCTS WITH CASSETTE ARRANGEMENTS FOR INCREASED TRANSCRIPTION OF RNA PAYLOADS | Shape Therapeutics Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| EP-4694922-A1 | HIV VACCINE | BioNTech SE (DE) | 2026-02-18 | — | — | EP | disclosed |
| EP-4652279-A2 | COMPOSITIONS FOR MODULATING KRAS EXPRESSION AND USES THEREOF | Molecular Axiom, LLC (US) | 2025-11-26 | — | — | EP | disclosed |
| EP-4608440-A1 | RNA MOLECULES ENCODING RSV-F AND VACCINES CONTAINING THEM | Pfizer Inc. (US) | 2025-09-03 | — | — | EP | disclosed |
| EP-4587579-A1 | SYSTEMS AND COMPOSITIONS COMPRISING TRANS-AMPLIFYING RNA VECTORS WITH MIRNA | BioNTech SE (DE) | 2025-07-23 | — | — | EP | disclosed |
| WO-2025137576-A1 | MULTIPLE SPECIFIC ANTIBODIES TARGETING CD19, CD20, AND/OR CD47 | NUTCRACKER THERAPEUTICS, INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| WO-2025126071-A1 | RNA MOLECULES | PFIZER INC. (US) | 2025-06-19 | — | — | WO | disclosed |
| WO-2025122824-A1 | MULTIVALENT ANTIBODY CONSTRUCTS FOR TARGETING PROSTATE CANCER CELLS | NUTCRACKER THERAPEUTICS, INC. (US) | 2025-06-12 | — | — | WO | disclosed |
| EP-4539876-A2 | RECOMBINANT RNA MOLECULES COMPRISING UNTRANSLATED REGIONS OR SEGMENTS ENCODING SPIKE PROTEIN FROM THE OMICRON STRAIN OF SEVERE ACUTE RESPIRATORY CORONAVIRUS-2 | GlaxoSmithKline Biologicals S.A. (BE) | 2025-04-23 | — | — | EP | disclosed |
| WO-2024238584-A1 | ENGINEERED CONSTRUCTS WITH CASSETTE ARRANGEMENTS FOR INCREASED TRANSCRIPTION OF RNA PAYLOADS | SHAPE THERAPEUTICS INC. (US) | 2024-11-21 | — | — | WO | disclosed |
| EP-4225913-A1 | ARTIFICIAL NUCLEIC ACIDS FOR RNA EDITING | Eberhard-Karls-Universität Tübingen (DE) | 2023-08-16 | — | — | EP | disclosed |
| WO-2023066875-A1 | MODIFIED REPLICABLE RNA AND RELATED COMPOSITIONS AND THEIR USE | BioNTech SE (DE) | 2023-04-27 | — | — | WO | disclosed |
| WO-2023066874-A1 | METHODS FOR DETERMINING MUTATIONS FOR INCREASING MODIFIED REPLICABLE RNA FUNCTION AND RELATED COMPOSITIONS AND THEIR USE | BioNTech SE (DE) | 2023-04-27 | — | — | WO | disclosed |
| WO-2023034537-A1 | COMPOSITIONS AND METHODS FOR MODULATING KRAS EXPRESSION | MOLECULAR AXIOM, LLC (US) | 2023-03-09 | — | — | WO | disclosed |
| WO-2023034538-A1 | COMPOSITIONS AND METHODS FOR MODULATING NLRP3 OR NLRP1 EXPRESSION | MOLECULAR AXIOM, LLC (US) | 2023-03-09 | — | — | WO | disclosed |
| WO-2023021421-A1 | LOW-DOSE LYOPHILIZED RNA VACCINES AND METHODS FOR PREPARING AND USING THE SAME | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2023-02-23 | — | — | WO | disclosed |
| WO-2023288289-A2 | OLIGONUCLEOTIDES AND COMPOSITIONS THEREOF FOR NEUROMUSCULAR DISORDERS | MIRECULE, INC. (US) | 2023-01-19 | — | — | WO | disclosed |
| WO-2022226377-A1 | COMPOSITIONS AND METHODS FOR MODULATING SOS GENE EXPRESSIONS | MOLECULAR AXIOM, LLC (US) | 2022-10-27 | — | — | WO | disclosed |
| WO-2022078995-A1 | ARTIFICIAL NUCLEIC ACIDS FOR RNA EDITING | EBERHARD KARLS UNIVERSITÄT TÜBINGEN (DE) | 2022-04-21 | — | — | WO | disclosed |
| WO-2022078569-A1 | ARTIFICIAL NUCLEIC ACIDS FOR RNA EDITING | EBERHARD KARLS UNIVERSITÄT TÜBINGEN (DE) | 2022-04-21 | — | — | WO | disclosed |